SKI Market

A+| A| A-|

Indian Indices

Sensex

77,155.62 347.14
( 0.45%)

Global Indices

Nasdaq

52,022.73 330.70
(0.64%)

Dow Jones

7,531.82 -43.47
(-0.57%)

Hang Seng

69,975.80 571.30
(0.82%)

Nikkei 225

10,505.62 11.41
(0.11%)

Forex

USD-INR

94.63 -0.29
(-0.31%)

EUR-INR

109.79 -0.04
(-0.03%)

GBP-INR

127.09 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

36.81

909.55

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.06

Back

Board of Laurus Labs recommends Second Interim dividend

Apr 30,2026

Laurus Labs announced that the Board of Directors of the Company at its meeting held on 30 April 2026, inter alia, have recommended the Second Interim dividend of Rs 1.2 per equity Share (i.e. 60%) , subject to the approval of the shareholders.

77,155.62 347.14 ( 0.45%)

52,022.73 330.70 (0.64%)

7,531.82 -43.47 (-0.57%)

69,975.80 571.30 (0.82%)

10,505.62 11.41 (0.11%)

94.63 -0.29 (-0.31%)

109.79 -0.04 (-0.03%)

127.09 -0.16 (-0.13%)

0.59 0.00 (-0.29%)